Clinical Trial: A Study of SSS68 Following a Single Subcutaneous Administration in Healthy Adult Participants

U.S., May 27 -- ClinicalTrials.gov registry received information related to the study (NCT07606976) titled 'A Study of SSS68 Following a Single Subcutaneous Administration in Healthy Adult Participants' on May 19.

Brief Summary: This is a randomized, double-blind, placebo-controlled, single ascending dose phase I clinical study to evaluate the safety, tolerability, PK, PD and immunogenicity of SSS68 in healthy adult participants following a single subcutaneous administration.

Study Start Date: June, 2026

Study Type: INTERVENTIONAL

Condition: Healthy

Intervention: DRUG: SSS68

A single dose of SSS68 will be administered SC on Day 1.

DRUG: Placebo

A single dose of placebo will be administered SC on Day 1.

Recruitment Status: NOT_YET...